B Hertenstein Selected Research

B Hertenstein Research Topics

5	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2023 - 10/2001
5	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 11/2017 - 05/2000
4	Leukemia 05/2013 - 05/2001
3	Infections 01/2017 - 12/2001
3	Graft vs Host Disease (Graft-Versus-Host Disease) 08/2010 - 01/2002
3	Autoimmune Diseases (Autoimmune Disease) 08/2002 - 05/2000
2	Aplastic Anemia (Anemia, Hypoplastic) 07/2008 - 11/2004
2	Neoplasms (Cancer) 02/2005 - 12/2001
2	Multiple Myeloma 11/2004 - 09/2003
2	Systemic Scleroderma (Systemic Sclerosis) 08/2004 - 06/2001
2	Multiple Sclerosis 08/2002 - 05/2000
1	Sarcoma (Soft Tissue Sarcoma) 10/2015
1	Invasive Fungal Infections 05/2013
1	Fever (Fevers) 05/2013
1	Febrile Neutropenia 05/2013
1	Leukocytosis (Pleocytosis) 09/2012
1	Bone Marrow Failure Disorders 07/2008
1	Infertility (Sterility) 01/2007
1	Myocardial Infarction 01/2007
1	Capillary Leak Syndrome 12/2004
1	Thrombotic Microangiopathies 12/2004
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 11/2004
1	Lymphoma (Lymphomas) 11/2004
1	Exanthema (Rash) 01/2002
1	Thrombocytopenia (Thrombopenia) 01/2002
1	Acute Liver Failure (Fulminant Hepatic Failure) 01/2002
1	Communicable Diseases (Infectious Diseases) 12/2001
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 06/2001
1	Skin Diseases (Skin Disease) 06/2001
1	Breast Neoplasms (Breast Cancer) 06/2001
1	Genetic Translocation (Chromosomal Translocation) 05/2000
1	Myeloproliferative Disorders (Myeloproliferative Disorder) 02/2000
1	Eosinophilia 02/2000

4	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2023 - 01/2017
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2015 - 09/2003
3	Proteins (Proteins, Gene)FDA Link 09/2012 - 05/2000
2	InterferonsIBA 11/2017 - 02/2000
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2023
1	Azacitidine (5 Azacytidine)FDA Link 01/2019
1	Imatinib Mesylate (Gleevec)FDA Link 11/2017
1	DNA Methyltransferase 3AIBA 01/2017
1	pegfilgrastim (Neulasta)FDA Link 01/2017
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2017
1	Tyrosine Kinase InhibitorsIBA 03/2016
1	Topotecan (Hycamtin)FDA LinkGeneric 10/2015
1	Voriconazole (Vfend)FDA LinkGeneric 05/2013
1	cyclo(Arg-Pro) (CI 4)IBA 08/2010
1	PotassiumIBA 01/2007
1	Minor Histocompatibility AntigensIBA 02/2004
1	Busulfan (Busulfex)FDA Link 09/2003
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 06/2002
1	Biomarkers (Surrogate Marker)IBA 06/2001
1	HLA-DR4 Antigen (HLA DR4 Antigen)IBA 05/2000

10	Stem Cell Transplantation 03/2016 - 05/2000
5	Hematopoietic Stem Cell Transplantation 05/2013 - 12/2001
5	Transplantation 08/2002 - 05/2000
4	Drug Therapy (Chemotherapy) 01/2023 - 09/2003
4	Therapeutics 01/2019 - 01/2007
3	Bone Marrow Transplantation (Transplantation, Bone Marrow) 10/2001 - 05/2000
1	Platelet Transfusion (Blood Platelet Transfusions) 01/2017
1	Induction Chemotherapy 10/2015
1	Liver Transplantation 01/2002
1	Homologous Transplantation 12/2001